Skip to main content
    C

    Co-Diagnostics, Inc. Common Stock (CODX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.22
    -0.03 (-13.03%)

    Market Cap: $2.72M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Co-Diagnostics, Inc. Common Stock (CODX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Co-Diagnostics, Inc. Common Stock are GlucoTrack (GCTK), Trinity Biotech (TRIB) and Nuwellis (NUWE). By market cap, Co-Diagnostics, Inc. Common Stock ranks 10th of the 13 companies on this page; Volitionrx (VNRX) is the largest at $8.30M.

    Peer Comparison

    CODX's revenue growth of 94.6% is above the peer median of 7.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Co-Diagnostics, Inc. Common Stock (CODX)$2.72MN/A1.6x0.0%N/A94.6%0.00%
    GlucoTrack Inc (GCTK)$2.43MN/AN/A0.0%-6319.2%0.0%0.00%
    Trinity Biotech plc (TRIB)$4.96MN/AN/A-85.4%-14.3%-5.5%0.00%
    Nuwellis Inc (NUWE)$2.65MN/AN/A-125.6%N/A14.1%0.00%
    Beyond Air Inc (XAIR)$3.55MN/A0.5x0.0%-113.5%0.5%0.00%
    Vivos Therapeutics Inc (VVOS)$3.29MN/A0.1x-121.8%-237.8%34.9%0.00%
    Icecure Medical (ICCM)$3.39MN/A0.6x0.0%N/A72.8%0.00%
    Tenon Medical Inc (TNON)$3.79MN/A0.3x-257.9%N/A126.8%0.00%
    Intelligent Bio Solutions Inc. (INBS)$5.84MN/A1.0x-269.3%N/A25.2%0.00%
    INVO Fertility, Inc. (IVF)$3.10MN/A0.2x-92.3%-36.1%16.7%0.00%
    Nexalin Technology Inc. (NXL)$1.83MN/A4.4x0.0%-609.2%-82.8%0.00%
    enVVeno Medical Corp (NVNO)$4.29MN/AN/A0.0%N/A0.0%0.00%
    Volitionrx Ltd (VNRX)$8.30MN/A2.0x0.0%83.7%-2.0%0.00%
    Peer median$3.47MN/A0.6x-42.7%-113.5%7.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Co-Diagnostics, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    GlucoTrack Inc (GCTK)
    GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes...
    GCTK competitors
    Trinity Biotech plc (TRIB)
    Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments...
    TRIB competitors
    Nuwellis Inc (NUWE)
    Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy.
    NUWE competitors
    Beyond Air Inc (XAIR)
    Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems.
    XAIR competitors
    Vivos Therapeutics Inc (VVOS)
    Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered...
    VVOS competitors
    Icecure Medical (ICCM)
    IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets.
    ICCM competitors
    Tenon Medical Inc (TNON)
    Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and outcomes.
    TNON competitors
    Intelligent Bio Solutions Inc. (INBS)
    Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven...
    INBS competitors
    INVO Fertility, Inc. (IVF)
    INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.
    IVF competitors
    Nexalin Technology Inc. (NXL)
    Nexalin Technology Inc. is a pioneering medical technology firm dedicated to transforming the treatment of neurological and psychiatric disorders through its...
    NXL competitors
    enVVeno Medical Corp (NVNO)
    enVVeno Medical Corp (NVNO) is a pioneering medical device firm focused on revolutionizing vascular access solutions for dialysis patients with its proprietary...
    NVNO competitors
    Volitionrx Ltd (VNRX)
    VolitionRx Limited, a multinational epigenetics company, is dedicated to developing blood tests to help diagnose a variety of cancers and other diseases...
    VNRX competitors

    Frequently Asked Questions About CODX

    Who are Co-Diagnostics, Inc. Common Stock's main competitors?

    The companies most similar to Co-Diagnostics, Inc. Common Stock include GlucoTrack (GCTK), Trinity Biotech (TRIB), Nuwellis (NUWE), Beyond Air (XAIR) and Vivos Therapeutics (VVOS), listed from the closest match.

    Who is Co-Diagnostics, Inc. Common Stock's biggest competitor?

    Volitionrx (VNRX) is the largest of the similar companies at $8.30M; GlucoTrack (GCTK) is the closest match by business profile, size, sector and industry.

    How does CODX stock compare with its competitors?

    CODX's P/S is 1.6x against a peer median of 0.6x; its net margin is 0.0% against a peer median of -42.7%.

    Which of Co-Diagnostics, Inc. Common Stock's competitors pays a higher dividend?

    Co-Diagnostics, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Co-Diagnostics, Inc. Common Stock bigger than its competitors?

    No. Co-Diagnostics, Inc. Common Stock is 10th by market cap among the 13 companies on this page; the largest is Volitionrx (VNRX) at $8.30M.